DILATRATE-SR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dilatrate-sr, and when can generic versions of Dilatrate-sr launch?
Dilatrate-sr is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in DILATRATE-SR is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dilatrate-sr
A generic version of DILATRATE-SR was approved as isosorbide dinitrate by ENDO OPERATIONS on March 12th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DILATRATE-SR?
- What are the global sales for DILATRATE-SR?
- What is Average Wholesale Price for DILATRATE-SR?
Summary for DILATRATE-SR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 3,870 |
| DailyMed Link: | DILATRATE-SR at DailyMed |
US Patents and Regulatory Information for DILATRATE-SR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | DILATRATE-SR | isosorbide dinitrate | CAPSULE, EXTENDED RELEASE;ORAL | 019790-001 | Sep 2, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
